Previously, it was demonstrated in breast cancer (BC) cell lines grown as xenografts that SMAD2/3 signaling played a dominant role in mediating tumor suppressor effects on well-differentiated BC lines but pro-metastatic functions on a more invasive, metastatic BC cell line (50). The gene discussed is SMAD2; the disease is breast cancer.